It is important to note that glioma stem cells (GCS) may activate C3 with the help of alternative pathways and activate STAT-3, ERK2/1, and PI3K/Akt/mTOR pathways to maintain their pluripotent state42. This evidence concerns the gene MTOR and central nervous system cancer.